Tag: Teva Pharmaceutical Industries

Teva’s AJOVY shows promising results in migraine prevention Phase IV study

businessnewstoday- July 1, 2023

New interim analysis from the pan-European PEARL Phase IV study reveals that Teva Pharmaceutical Industries' AJOVY (fremanezumab) has led to a significant reduction in monthly ... Read More

Teva Pharmaceuticals, MedinCell get UZEDY FDA approval for schizophrenia

businessnewstoday- April 30, 2023

Teva Pharmaceuticals and MedinCell have bagged approval for UZEDY (risperidone) extended-release injectable suspension from the US Food and Drug Administration (FDA) for schizophrenia treatment in ... Read More

NATCO Pharma launches lenalidomide 2.5mg and 20mg in US

businessnewstoday- March 12, 2023

NATCO Pharma said that it has launched additional strengths for the generic version of Revlimid (lenalidomide capsules), in the strengths of 2.5mg and 20mg in ... Read More

Teva Pharmaceutical gets FDA approval for AUSTEDO XR for TD and HD

businessnewstoday- February 19, 2023

Teva Pharmaceutical Industries said that its US affiliate Teva Pharmaceuticals has secured approval for AUSTEDO XR (deutetrabenazine) extended-release tablets from the US Food and Drug ... Read More

Natco Pharma gets FDA approval for Lenalidomide Capsules

pallavi123- May 24, 2021

Natco Pharma has secured the final approval from the US Food and Drug Administration (FDA) of its abbreviated new drug application (ANDA) for Lenalidomide Capsules, ... Read More

Fresenius Kabi launches leukemia drug Trisenox generic in US

pharmanewsdaily- November 4, 2018

German health care company Fresenius Kabi has announced the US launch of Arsenic Trioxide Injection - a generic version of Teva Pharmaceutical Industries’ leukemia drug ... Read More

Ajovy FDA approval : Teva’s Ajovy approved in US for migraine prevention

pharmanewsdaily- September 16, 2018

Ajovy FDA approval : Israeli pharma company Teva Pharmaceutical Industries has bagged the US Food and Drug Administration (FDA) approval for Ajovy (fremanezumab-vfrm) injection to ... Read More

Teva, Regeneron report positive data for fasinumab in phase 3 osteoarthritis trial

pharmanewsdaily- August 19, 2018

Teva Pharmaceutical Industries and Regeneron Pharmaceuticals said that a phase 3 study evaluating nerve growth factor (NGF) antibody fasinumab in patients with chronic pain from ... Read More

Teva job cuts : Israeli pharma company to remove 14,000 employees

pallavi123- December 16, 2017

Teva job cuts : Teva Pharmaceutical Industries, the Israel-based generic drug maker has announced its decision of removing 14,000 employees across its global operations under ... Read More